1. Home
  2. XPL vs XGN Comparison

XPL vs XGN Comparison

Compare XPL & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Solitario Resources Corp.

XPL

Solitario Resources Corp.

HOLD

Current Price

$0.79

Market Cap

74.8M

ML Signal

HOLD

Logo Exagen Inc.

XGN

Exagen Inc.

HOLD

Current Price

$4.67

Market Cap

71.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XPL
XGN
Founded
1984
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Precious Metals
Medical Specialities
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
74.8M
71.2M
IPO Year
2000
2014

Fundamental Metrics

Financial Performance
Metric
XPL
XGN
Price
$0.79
$4.67
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
7
Target Price
$1.20
$8.86
AVG Volume (30 Days)
248.7K
401.9K
Earning Date
05-04-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
42.86
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$8.12
Revenue Next Year
N/A
$13.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.54
$2.59
52 Week High
$0.98
$12.23

Technical Indicators

Market Signals
Indicator
XPL
XGN
Relative Strength Index (RSI) 44.62 57.89
Support Level $0.68 $2.68
Resistance Level $0.81 $5.55
Average True Range (ATR) 0.03 0.42
MACD -0.01 -0.07
Stochastic Oscillator 38.27 36.81

Price Performance

Historical Comparison
XPL
XGN

About XPL Solitario Resources Corp.

Solitario Resources Corp is an exploration company engaging in acquiring, exploring, and developing zinc properties and other precious metals in safe jurisdictions in North and South America. Its core mineral property assets are: the Florida Canyon zinc project in Peru, the Lik zinc project in Alaska, and the Golden Crest project in South Dakota. Additionally, Solitario holds an interest in the Chambara project in Peru and also has two early-stage projects, the Cat Creek project and the Bright Angel project in Colorado. The company is conducting mineral exploration on its Golden Crest project, the Cat Creek project, and the Bright Angel project on its own.

About XGN Exagen Inc.

Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, autoimmune, and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company operates in one operating segment. The majority of the company's revenue is derived from sales of its testing products.

Share on Social Networks: